Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival
Por:
de Witte, T, Brand, R, van Biezen, A, Mufti, G, Ruutu, T, Finke, J, von dem Borne, P, Vitek, A, Delforge, M, Alessandrino, P, Harlahakis, N, Russell, N, Martino, R, Verdonck, L, Kroger, N, Niederwieser, D
Publicada:
1 sep 2009
Resumen:
P>Allogeneic stem cell transplantation (alloSCT) for patients with refractory anaemia may result in a 50% event-free survival, but the high non-relapse mortality (NRM) precludes a general application of this therapeutic modality. This study evaluated the impact of various pre-transplant variables, including disease duration, intensity of the conditioning regimen, type of donor and year of transplantation on outcome. The study population consisted of 374 patients; 244 were transplanted from human leucocyte antigen (HLA)-identical siblings and 130 patients from matched unrelated donors. The median age was 39 years. One hundred and two patients were transplanted after reduced intensity conditioning (RIC). The overall 4-year survival was 52%. The 4-year survival of patients transplanted with HLA-identical sibling donors and matched unrelated donors was 52% and 50%, respectively. Multivariate analysis showed an improved survival (P = 0 center dot 05) and a lower NRM (P = 0 center dot 02) when the transplantation was performed in recent years. Increasing age, and disease duration of > 12 months were associated with inferior survival. RIC resulted in a similar survival despite an increased relapse risk (P = 0 center dot 02). This improved outcome permits alloSCT in patients older than 50 years of age, even with the use of matched unrelated donors. AlloSCT should be preferentially performed early after diagnosis after careful analysis of prognostic variables.
Filiaciones:
de Witte, T:
Univ Med Ctr Nijmegen, Nijmegen, Netherlands
Brand, R:
Leiden Univ, Med Ctr, Leiden, Netherlands
van Biezen, A:
Leiden Univ, Med Ctr, Leiden, Netherlands
Mufti, G:
GKT Sch Med, London, England
Ruutu, T:
Univ Helsinki, Cent Hosp, Helsinki, Finland
Finke, J:
Univ Freiburg, Freiburg, Germany
von dem Borne, P:
Leiden Univ, Med Ctr, Leiden, Netherlands
Vitek, A:
Inst Hematol & Blood Transfus, Prague, Czech Republic
Delforge, M:
Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
Alessandrino, P:
Policlin San Matteo, I-27100 Pavia, Italy
Harlahakis, N:
Evangelismos Med Ctr, Athens, Greece
Russell, N:
Univ Nottingham Hosp, Nottingham NG7 2UH, England
Martino, R:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Verdonck, L:
Univ Med Ctr Utrecht, Utrecht, Netherlands
Kroger, N:
Univ Hosp Eppendorf, Hamburg, Germany
Niederwieser, D:
Univ Leipzig, Leipzig, Germany
Bronze
|